All In MedTech

FDA Clearance Tracker · P110023-S056

EVERFLEX SELF-EXPANDING PERIPHERAL STENT SYSTEM (EVERFLEX)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 5, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P110023-S056
Device name
EVERFLEX SELF-EXPANDING PERIPHERAL STENT SYSTEM (EVERFLEX)
Applicant location
Plymouth, MN
Received
Jan 30, 2025
Decided
Aug 5, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P110023

Device type

Device class
Class III

Every decision under product code NIP

FDA's approval statement

As written in FDA's record.

Approval for a line extension for the SFA/PPA indication, which includes the addition of a 5.0mm stent diameter and reduction in minimum rated vessel diameter to 4.0 mm

Source documents

Other decisions for Medtronic Vascular, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.